argenx SE reported $203.84M in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
AstraZeneca USD 3.51B 166M Jun/2025
Galapagos EUR -57027000 101.68M Jun/2025
Genmab DKK 360M 172M Jun/2025
GlaxoSmithKline GBP 2.02B 193M Jun/2025
GRIFOLS EUR 349.54M 80.68M Jun/2025
Hikma Pharmaceutical USD 282M 45M Dec/2024
Qiagen NV USD 135.97M 10.81M Jun/2025
UCB EUR 1B 678M Dec/2024